CL2016000392A1 - Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune - Google Patents
Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmuneInfo
- Publication number
- CL2016000392A1 CL2016000392A1 CL2016000392A CL2016000392A CL2016000392A1 CL 2016000392 A1 CL2016000392 A1 CL 2016000392A1 CL 2016000392 A CL2016000392 A CL 2016000392A CL 2016000392 A CL2016000392 A CL 2016000392A CL 2016000392 A1 CL2016000392 A1 CL 2016000392A1
- Authority
- CL
- Chile
- Prior art keywords
- diseases
- treatment
- inflammatory
- immune component
- cortistatin analogues
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- DDRPLNQJNRBRNY-WYYADCIBSA-N cortistatin-14 Chemical class C([C@H]1C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N1)NC(=O)[C@H]1NCCC1)C(=O)N[C@@H](CCCCN)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 DDRPLNQJNRBRNY-WYYADCIBSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Birds (AREA)
Abstract
ANÁLOGOS DE CORTISTATINA PARA EL TRATAMIENTO DE ENFERMEDADES CON COMPONENTE INFLAMATORIO Y/O INMUNE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382361 | 2013-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016000392A1 true CL2016000392A1 (es) | 2016-11-11 |
Family
ID=49880656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016000392A CL2016000392A1 (es) | 2013-09-18 | 2016-02-22 | Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US12297294B2 (es) |
| EP (1) | EP3046933B1 (es) |
| JP (1) | JP6989260B2 (es) |
| KR (1) | KR102285939B1 (es) |
| CN (1) | CN105579467B (es) |
| AU (1) | AU2014323131B2 (es) |
| BR (1) | BR112016005731B1 (es) |
| CA (1) | CA2921324C (es) |
| CL (1) | CL2016000392A1 (es) |
| DK (1) | DK3046933T3 (es) |
| ES (1) | ES2728319T3 (es) |
| HU (1) | HUE043206T2 (es) |
| IL (1) | IL244317B (es) |
| LT (1) | LT3046933T (es) |
| MX (1) | MX368373B (es) |
| MY (1) | MY185593A (es) |
| NZ (1) | NZ717035A (es) |
| PL (1) | PL3046933T3 (es) |
| PT (1) | PT3046933T (es) |
| RU (1) | RU2678315C2 (es) |
| SG (1) | SG11201601036UA (es) |
| UA (1) | UA119148C2 (es) |
| WO (1) | WO2015040089A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20160291A (es) | 2013-12-24 | 2017-02-24 | Harvard College | Análogos de cortistatina y síntesis y usos de los mismos |
| WO2016182932A1 (en) | 2015-05-08 | 2016-11-17 | President And Fellows Of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
| WO2017004411A1 (en) | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
| WO2019010310A1 (en) * | 2017-07-05 | 2019-01-10 | Wisconsin Alumni Research Foundation | MINERAL-COATED MICROPARTICLES FOR CO-ADMINISTRATION OF ANTI-INFLAMMATORY MOLECULES AND NUCLEIC ACIDS TO IMPROVE GENE DELIVERY RESULTS |
| US12161748B2 (en) | 2018-01-31 | 2024-12-10 | Twi Biotechnology, Inc. | Topical formulations comprising tofacitinib |
| CA3089108A1 (en) * | 2018-01-31 | 2019-08-08 | Twi Pharmaceuticals, Inc. | Topical formulations comprising tofacitinib |
| CA3093594A1 (en) | 2018-03-29 | 2019-10-03 | Lateral IP Pty Ltd | Cyclic peptides and uses thereof |
| RU2698451C1 (ru) * | 2018-07-02 | 2019-08-27 | Павел Александрович Храмов | Средство и способ для лечения нейросенсорной тугоухости |
| ES2780274A1 (es) * | 2019-02-15 | 2020-08-24 | Consejo Superior De Investig Científicas (Csic) | Cortistatina o un análogo de la misma como agente farmacéuticamente activo en forma latente |
| AU2020397424B2 (en) * | 2019-12-05 | 2025-12-04 | Bcn Peptides, S.A. | Peptides for the treatment of cancer and/or metastasis |
| CN111297876B (zh) * | 2020-01-16 | 2021-04-27 | 武汉理工大学 | 一种塞来昔布胶束和和厚朴酚胶束药物联用控释系统及其制备方法 |
| CN115120702A (zh) * | 2020-03-30 | 2022-09-30 | 山东大学齐鲁医院 | 皮质抑素14在制备银屑病治疗药物中的应用 |
| CN113797314B (zh) * | 2021-09-29 | 2023-08-22 | 山东大学齐鲁医院 | Cst多肽在制备股骨头坏死治疗药物中的应用 |
| CN114949174B (zh) * | 2022-07-19 | 2025-09-30 | 山东大学齐鲁医院 | Cst-14在制备糖尿病皮肤溃疡、破损治疗药物中的应用 |
| CN117866953B (zh) * | 2023-03-02 | 2025-03-07 | 江西省人民医院 | 靶向生长激素释放抑制激素基因的shRNA及其医药应用 |
| CN117567554B (zh) * | 2023-11-16 | 2025-03-07 | 中国科学技术大学 | 一种荷载抗炎药的凝胶因子、水凝胶及制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997046668A1 (en) * | 1996-06-07 | 1997-12-11 | Takeda Chemical Industries, Ltd. | Novel peptide, process for the production of the same, and use of the same |
| US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| EP1040837A3 (en) | 1999-02-26 | 2002-01-02 | Erasmus Universiteit Rotterdam | Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder |
| EP1978987B1 (en) | 2006-01-05 | 2014-12-31 | University of Utah Research Foundation | Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| WO2007082980A1 (es) * | 2006-01-23 | 2007-07-26 | Consejo Superior De Investigaciones Científicas | Composiciones y procedimientos para tratar trastornos inflamatorios e inmunitarios con cortistatina |
| WO2009043523A2 (en) | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| EP2168983A1 (fr) | 2008-09-30 | 2010-03-31 | Ipsen Pharma | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
| ES2351569B8 (es) | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
-
2014
- 2014-09-17 NZ NZ71703514A patent/NZ717035A/en unknown
- 2014-09-17 EP EP14766508.7A patent/EP3046933B1/en active Active
- 2014-09-17 UA UAA201601741A patent/UA119148C2/uk unknown
- 2014-09-17 KR KR1020167008345A patent/KR102285939B1/ko active Active
- 2014-09-17 HU HUE14766508A patent/HUE043206T2/hu unknown
- 2014-09-17 PT PT14766508T patent/PT3046933T/pt unknown
- 2014-09-17 LT LTEP14766508.7T patent/LT3046933T/lt unknown
- 2014-09-17 JP JP2016543392A patent/JP6989260B2/ja active Active
- 2014-09-17 AU AU2014323131A patent/AU2014323131B2/en active Active
- 2014-09-17 PL PL14766508T patent/PL3046933T3/pl unknown
- 2014-09-17 SG SG11201601036UA patent/SG11201601036UA/en unknown
- 2014-09-17 BR BR112016005731-7A patent/BR112016005731B1/pt active IP Right Grant
- 2014-09-17 CA CA2921324A patent/CA2921324C/en active Active
- 2014-09-17 US US14/912,343 patent/US12297294B2/en active Active
- 2014-09-17 MY MYPI2016000336A patent/MY185593A/en unknown
- 2014-09-17 WO PCT/EP2014/069842 patent/WO2015040089A1/en not_active Ceased
- 2014-09-17 ES ES14766508T patent/ES2728319T3/es active Active
- 2014-09-17 MX MX2016003490A patent/MX368373B/es active IP Right Grant
- 2014-09-17 CN CN201480048751.9A patent/CN105579467B/zh active Active
- 2014-09-17 DK DK14766508.7T patent/DK3046933T3/da active
- 2014-09-17 RU RU2016109410A patent/RU2678315C2/ru active
-
2016
- 2016-02-22 CL CL2016000392A patent/CL2016000392A1/es unknown
- 2016-02-28 IL IL244317A patent/IL244317B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000392A1 (es) | Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune | |
| LT3206715T (lt) | Kanabidiolio naudojimas tuberozinės sklerozės komplekso gydymui | |
| CL2016000424A1 (es) | Métodos y composiciones para el arn-guiado tratamiento de la infección por vih | |
| IL244111A0 (en) | Survival benefit in patients with solid tumors with elevated c-reactive protein levels | |
| BR112018010464A2 (pt) | formulações farmacêuticas tópicas para tratar condições inflamatórias relacionadas | |
| IL241112B (en) | Methods and compositions for modification of hla | |
| LT3335708T (lt) | Įvedimas gama hidroksibutirato su monokarboksilato transporteriais | |
| EP2890806A4 (en) | PROCESSING BIOMASS | |
| PL2968306T3 (pl) | Podawanie mononukleotydu nikotynamidu do leczenia zespołu suchego oka | |
| EP2968208A4 (en) | TREATMENT OF CATAPLEXIA | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| CL2016000326A1 (es) | Composiciones y método para tratar condiciones asociadas con el complemento | |
| HRP20170840T1 (hr) | Supstituirani ksantini i metode njihove uporabe | |
| PL3007687T3 (pl) | Kombinacja pentacyklicznych triterpenów i hydroksytyrozolu oraz jego pochodnych | |
| DE112015001114A5 (de) | Herstellung optoelektronischer Bauelemente | |
| CL2016001098A1 (es) | Uso de cisteamina y sus derivados para el tratamiento de enfermedades mitocondriales | |
| IL246269B (en) | Compositions and methods for treating fatty tissue buildup | |
| HRP20190397T1 (hr) | Jednodozni inhalator s prahom i postupak njegove proizvodnje | |
| LT3297653T (lt) | Postbariatrinės hipoglikemijos gydymas glp-1 antagonistais | |
| LT3307267T (lt) | Išsėtinės sklerozės gydymas | |
| BR112015016577A2 (pt) | elemento de fixação e seringa | |
| IL254825A0 (en) | Methods of treatment with taselisib | |
| IL258630B1 (en) | Formulation of l-ornithine phenylacetate | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| BR112015024771A2 (pt) | cateter |